Dr Takami Sato Discusses IMCgp100 Treatment for Metastatic Uveal Melanoma

Source: Rare Disease Report, June 2018

In a recent interview with Rare Disease Report^®, Takami Sato, MD, PhD, from the department of Medical Oncology at Kimmel Cancer Center, Thomas Jefferson University, discussed the use of IMCgp100 as a treatment for metastatic uveal melanoma (mUM).

Dr Sato was the lead investigator of a phase 1/2 study which evaluated the safety and preliminary efficacy of IMCgp100 in mUM patients; the findings were presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.